NCT03509246 2020-01-14Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer PatientsSeoul National University HospitalPhase 2 Unknown44 enrolled